Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
To find a recommended dose of attIL2-TIL cell therapy that can be given to participant with either relapsed or metastatic sarcomas (has come back or spread to …
Metastatic Soft-tissue Sarcoma
M.D. Anderson Cancer CenterNCT06474676
Phase 1
Phase I Study With Expansion Cohort of Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma
The investigators hypothesize that zanzalintinib in combination with ipilimumab and nivolumab will be well tolerated and serve as a potential therapeutic strat…
Metastatic Soft-tissue Sarcoma
Washington University School of MedicineNCT06968988